[1] 王辉,王江滨.肝炎病毒感染与酒精性肝硬化关系的研究(附182例酒精性肝病临床病例报告). 白求恩医科大学学报,1998,24(6):652-653. [2] Ozaki K,Kikly K,Michalovich D,et al. Cloning of a type I cytokine receptor most related to the IL-2 receptor beta chain. Proc Natl Acad Sci USA,2000,97(21):11439-11444. [3] Nakamoto N,Cho H,Shaked A,et al. Synergistic reversal of intrah-epatic HCV-specific CD8 T cell exhaustion by combined PD1/CTLA-4 blockade. PLoS Pathog,2009,5(2):e1000313. [4] Parrish-Novak J,Dillon SR,Nelson A,et al. Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function. Nature,2000,408(6808): 57-63. [5] Publicover J,Goodsell A,Nishimura S,et al. IL-21 is pivotal in determineing age-dependent effectiveness of immune responses in a mouse model of human hepatitis B.J Clin Invest,2011,121(3):1154-1162. [6] Hu X,Ma S,Huang X,et al. Interleukin-21 is upregulated in hepatitis B-related acute-on-chronic liver failure and associated with severity of liver disease. J Viral Hapat,2011,18(7):348-367. [7] 中华医学会肝脏病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊疗指南. 中华肝脏病杂志,2010,18(3);167-171. [8] Xu L,Hui AY,Albanis E,et al. Human hepatic stellate cell lines,LX-1 and LX-2:new tools for analysis of hepatic fibrosis. Gut,2005,54(1):142-151. [9] Iannello A,Boulassel MR,Samarani S, et al. Dynamics and consequences of IL-21 production in HIV-infected individuals:a longitudinal and cross-sectional study. J Immunol,2010,184(1):114-126. [10] Toomey JA,Gays F,Foster D,et al. Cytokine requirements for the growth and development of mouse NK cells in vitro. J Leukoc Biol,2003,74(2):233-242. [11] 易本谊,江和,杨生晟,等. 慢性乙型肝炎患者血清IL-21水平检测及意义. 细胞与分子免疫学杂志,2009,25(12):1167-1168. [12] 潘兴飞,张卡,杨小安. 慢加急性肝衰竭患者外周血IL-21水平检测及其意义. 中华实验和临床病毒学杂志,2012,26(6):477-479. [13] 莫菁莲,王政. 肝苏颗粒对慢性乙型肝炎患者IL-21的影响. 中国实验方剂学杂志,2013,19(8):284-286. [14] 尚雁君,胡志德,孙懿. 原发性胆汁性肝硬化患者血清IL-21增高及其意义. 中华检验医学杂志,2013,36(3):222-227. [15] 潘庆春,余永胜,汤正好,等. 慢性丙型肝炎患者血清IL-21水平检测及临床意义.中国临床药理学与治疗学,2013,18(2):190-194. [16] 邹敏,李珉珉,李晓娟,等. 不同治疗方案对慢性乙型肝炎患者血清白介素21水平的影响. 2012,32(9):1284-1286. [17] Karimi MH,Hejr S,Geramizadeh B,et al. Study of the relationships between IL-23R,IL-17,IL-21 polymorphisms and serum level of IL-17,IL-21 with acute graft rejection in Iranian liver transplant recipients. Immunol Invest,2014,43(1):69-85. [18] 王丽娜,鞠吉雨,梁淑娟,等. IL-21在肝癌细胞株H22细胞中的表达及其活性. 中国肿瘤生物治疗杂志,2010,17(2):174-178. [19] Li L,Liu M,Cheng LW,et al. HBcAg-specific IL-21-producing CD4 + T cells are associated with relative viral control in patients with chronic hepatitis B. Scand J Immunol,2013,78(5):439-446. [20] Ma SW,Huang X,Li YY,et al. High serum IL-21 levels after 12 weeks of antiviral therapy predict HBeAg seroconversion in chronic hepatitis B. J Hepatol,2012,56(4):775-781. [21] Laso FJ,Iglesias-Osma C,Ciudad J,et al. Alcoholic liver cirrhosis is associated with a decreased expression of the CD28 costimulatory molecule,a lower ability of T cells to bind exogenous IL-2,and increased soluble CD8 levels. Cytometry,2000,42(5):290-295. [22] McClain CJ,Cohen DA,Dinarello CA,et al. Serum interleukin-1(IL-1)activity in alcoholic hepatitis. Life Sci,1986,39(16): 1479-1485. [23] Petrasek J,Bala S,Csak T,et al. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Invest,2012,122(10):3476-3489. [24] 邢微微,朱 贺,龙民慧,等. 重组人IL-22 对大鼠酒精性肝炎的治疗效果评价. 军事医学,2011,35(8):607-610. [25] 余小虎,朱金水,邱夏地,等. 还原型谷胱甘肽对酒精性肝炎患者血清TNF-A、瘦素的影响. 实用肝脏病杂志,2005,8(3):140-142. |